Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution
- PMID: 9552470
- DOI: 10.3109/10837459709022640
Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution
Abstract
In this study, the degradation of Octastatin, a cyclic octapeptide analog of somatostatin, was examined as a function of pH, temperature, buffer, and ionic strength by reversed-phase gradient high-performance liquid chromatography. Degradation of Octastatin followed a first-order kinetics. Various buffer species such as acetate, ammonium acetate, citrate, glutamate, phosphate, and borate showed differing effects on the degradation of the octapeptide. Good stability was found in glutamate and acetate buffer of pH 4.0. Degradation of Octastatin was greater in citrate- or phosphate-containing buffers than in glutamate or acetate buffers. With phosphate buffer, higher buffer concentration caused greater degradation, while in acetate buffer, the effect of buffer concentration and ionic strength was negligible. In addition, the degradation of Octastatin was markedly inhibited by increasing the concentration of glutamate buffer. This study allows the prediction of good stability in acetate buffer (0.01 M, pH 4.0) with a t90% of 84.1 days at 20 degrees C.
Similar articles
-
Stability of ricobendazole in aqueous solutions.J Pharm Biomed Anal. 2009 Jul 12;49(5):1282-6. doi: 10.1016/j.jpba.2009.02.032. Epub 2009 Mar 13. J Pharm Biomed Anal. 2009. PMID: 19342190
-
Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.Am J Hosp Pharm. 1987 Oct;44(10):2287-90. Am J Hosp Pharm. 1987. PMID: 3687969
-
Stability of ertapenem in aqueous solutions.J Pharm Biomed Anal. 2007 Jan 17;43(2):445-9. doi: 10.1016/j.jpba.2006.07.021. Epub 2006 Aug 17. J Pharm Biomed Anal. 2007. PMID: 16914282
-
Stability of galactose in aqueous solutions.Am J Hosp Pharm. 1989 Jan;46(1):104-8. Am J Hosp Pharm. 1989. PMID: 2712020
-
Calcium buffer solutions and how to make them: a do it yourself guide.Can J Physiol Pharmacol. 1991 Nov;69(11):1733-49. doi: 10.1139/y91-257. Can J Physiol Pharmacol. 1991. PMID: 1804518 Review.
Cited by
-
Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.AAPS J. 2015 Jan;17(1):144-55. doi: 10.1208/s12248-014-9688-2. Epub 2014 Nov 15. AAPS J. 2015. PMID: 25398427 Free PMC article. Review.
-
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.Pharmaceutics. 2023 Mar 14;15(3):935. doi: 10.3390/pharmaceutics15030935. Pharmaceutics. 2023. PMID: 36986796 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources